South Dakota Investment Council Sells 5,000 Shares of Encompass Health Corporation $EHC

South Dakota Investment Council reduced its position in Encompass Health Corporation (NYSE:EHC – Free Report) by 9.6% in the third quarter, Holdings Channel.com reports. The fund owned 47,082 shares of the company’s stock after selling 5,000 shares during the quarter. South Dakota Investment Council’s holdings in Encompass Health were worth $5,720,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Transamerica Financial Advisors LLC purchased a new stake in shares of Encompass Health in the 2nd quarter valued at about $29,000. Toth Financial Advisory Corp bought a new stake in shares of Encompass Health during the 3rd quarter valued at about $38,000. Persistent Asset Partners Ltd purchased a new position in shares of Encompass Health during the second quarter worth about $36,000. Keating Financial Advisory Services Inc. purchased a new position in shares of Encompass Health during the second quarter worth about $39,000. Finally, Root Financial Partners LLC bought a new position in shares of Encompass Health in the third quarter worth approximately $52,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $134.93 on Thursday. The stock has a market cap of $13.24 billion, a PE ratio of 21.08, a PEG ratio of 2.39 and a beta of 0.83. The company’s fifty day moving average is $127.72 and its 200 day moving average is $112.68. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $143.90. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.73.

Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.16. Encompass Health had a net margin of 10.17% and a return on equity of 18.35%. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.60 billion. During the same period in the prior year, the business posted $1.23 earnings per share. The company’s revenue was up 8.9% on a year-over-year basis. Research analysts anticipate that Encompass Health Corporation will post 6.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, January 4th. Encompass Health’s payout ratio is 13.12%.

Insiders Place Their Bets

In related news, EVP John Darby sold 4,858 shares of the stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president directly owned 75,041 shares in the company, valued at $9,086,714.69. This represents a 6.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on EHC. KeyCorp lifted their target price on shares of Encompass Health from $147.00 to $150.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. UBS Group increased their price target on shares of Encompass Health from $155.00 to $165.00 and gave the stock a “buy” rating in a report on Friday, October 30th. Weiss Ratings upgraded shares of Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. TD Cowen lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, October 30th. Finally, Raymond James Financial reiterated a “strong-buy” rating and issued a $155.00 target price on shares of Encompass Health in a research report on Friday, October 30th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $154.25.

Check Out Our Latest Analysis on Encompass Health

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

Further Reading

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.